Literature DB >> 26902407

α-Hederin inhibits G protein-coupled receptor kinase 2-mediated phosphorylation of β2-adrenergic receptors.

Janka Schulte-Michels1, Anne Wolf1, Stefan Aatz1, Katharina Engelhard1, Anne Sieben1, Manuel Martinez-Osuna1, Felix Häberlein1, Hanns Häberlein2.   

Abstract

BACKGROUND: Recently is has been shown that α- and β-hederin increase the β2-adrenergic responsiveness of alveolar type II cells (A549) and human airway smooth muscle cells (HASM), respectively, by inhibiting the internalization of β2-adrenergic receptors (β2AR) under stimulating conditions. Internalization of β2AR is initiated by phosphorylations of certain serines and threonines by cAMP dependent protein kinase A (PKA) and G protein-coupled receptor kinases (GRK).
PURPOSE: To evaluate the effect of α-hederin on PKA and GRK2 mediated phosphorylation of GFP-tagged β2AR. STUDY
DESIGN: To study this process we performed In-Cell Western using isoprenaline stimulated HEK293 cells overexpressing β2AR as GFP fusion protein and specific antibodies against PKA (Ser345/346) and GRK2 (Ser355/356) phosphorylation sites.
RESULTS: There was no effect found on the PKA mediated phosphorylation (n = 14) but we could show that α-hederin (1 µM, 12 h) significantly inhibits GRK2 mediated phosphorylation at Ser355/356 by 11 ± 5% (n ≥ 29, p ≤ 0.01) under stimulating conditions compared to the positive control. In Förster resonance energy transfer (FRET) experiments using the isolated kinases in solution α-hederin did not show any influence neither to GRK2 nor to PKA.
CONCLUSION: Taken together, these results indicate that α-hederin acts as an indirect GRK2 inhibitor leading to a reduced homologous desensitization of β2AR-GFP in HEK293 cells.
Copyright © 2015 The Authors. Published by Elsevier GmbH.. All rights reserved.

Entities:  

Keywords:  GRK2; homologous desensitization; phosphorylation; α-hederin; β(2)-adrenergic receptor

Mesh:

Substances:

Year:  2015        PMID: 26902407     DOI: 10.1016/j.phymed.2015.12.001

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  6 in total

1.  Bioactive phenolics fraction of Hedera helix L. (Common Ivy Leaf) standardized extract ameliorates LPS-induced acute lung injury in the mouse model through the inhibition of proinflammatory cytokines and oxidative stress.

Authors:  Aya A Shokry; Riham A El-Shiekh; Gehan Kamel; Alaa F Bakr; Amer Ramadan
Journal:  Heliyon       Date:  2022-05-19

Review 2.  Natural Products Targeting the Mitochondria in Cancers.

Authors:  Yue Yang; Ping-Ya He; Yi Zhang; Ning Li
Journal:  Molecules       Date:  2020-12-28       Impact factor: 4.411

3.  α-Hederin Arrests Cell Cycle at G2/M Checkpoint and Promotes Mitochondrial Apoptosis by Blocking Nuclear Factor-κB Signaling in Colon Cancer Cells.

Authors:  Dongdong Sun; Weixing Shen; Feng Zhang; Huisen Fan; Jiani Tan; Liu Li; Changliang Xu; Haibin Zhang; Ye Yang; Haibo Cheng
Journal:  Biomed Res Int       Date:  2018-09-27       Impact factor: 3.411

4.  A comparative study on the influence of an ivy preparation and an ivy/thyme combination on the β2-adrenergic signal transduction.

Authors:  Hendrik Bussmann; Janka Schulte-Michels; Mara Bingel; Fabio Meurer; Stefan Aatz; Felix Häberlein; Sebastian Franken; Hanns Häberlein
Journal:  Heliyon       Date:  2020-05-15

5.  Efficacy of two dosing schemes of a liquid containing ivy leaves dry extract EA 575 versus placebo in the treatment of acute bronchitis in adults.

Authors:  Axel Schaefer; Fanny Ludwig; Bruno M Giannetti; Michael Bulitta; Anja Wacker
Journal:  ERJ Open Res       Date:  2019-12-08

6.  The influence of standardized dry ivy leaf extract on the proportion of nasal secretion after post-septoplasty nasal packing removal.

Authors:  Slobodan Savović; Milica Paut Kusturica; Vladimir Kljajić; Maja Buljčik Čupić; Ljiljana Jovančević; Vedrana Pavlović; Aleksandar Rašković
Journal:  Braz J Otorhinolaryngol       Date:  2018-06-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.